Transactions under Novozymes’ stock buyback program

As of March 20, Novozymes has purchased an accumulated 994,400 shares with a transaction value of DKK 242.5 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.

The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:      
 
 
Number
of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
778,400
192,264,172
March 14, 2014
45,000
230.16
10,357,089
March 17, 2014
43,000
231.78
9,966,451
March 18, 2014
44,000
233.75
10,284,931
March 19, 2014
42,000
233.86
9,822,055
March 20, 2014
42,000
232.20
9,752,317
Total accumulated under the program
994,400
242,447,015
 
In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 1,315 B shares in the period from March 14 to March 20, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
 
Following the transactions stated above, Novozymes owns a total of 5,420,842 treasury shares, corresponding to 1.7% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.
 
Contact information
Investor Relations:
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+44 7976138265
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282
Poonam Kapila (India)
+91 991 082 2339